The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Pharmacology behind Common Drug Nephrotoxicities
Open accessAbstract
Patients are exposed to numerous prescribed and over-the-counter medications. Unfortunately, drugs remain a relatively common cause of acute and chronic kidney injury. A combination of factors including the innate nephrotoxicity of drugs, underlying patient characteristics that increase their risk for kidney injury, and the metabolism and pathway of excretion by the kidneys of the various agents administered enhance risk for drug-induced nephrotoxicity. This paper will review these clinically relevant aspects of drug-induced nephrotoxicity for the clinical nephrologist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
Hoste, E. A. J., Bagshaw, S. M., Bellomo, R., Cely, C. M., Colman, R., Cruz, D. N., Edipidis, K., Forni, L. G., Gomersall, C. D., Govil, D., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3934-7 · Cited by 3,061
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Spectrum of acute renal failure in the intensive care unit: The PICARD experience
Mehta, R. L., Pascual, M. T., Soroko, S., Savage, B. R., Himmelfarb, J., Ikizler, T. A., Paganini, E. P., & Chertow, G. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00927.x · Cited by 962
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Cortazar, F. B., Marrone, K. A., Troxell, M. L., Ralto, K. M., Hoenig, M. P., Brahmer, J. R., Le, D. T., Lipson, E. J., Glezerman, I. G., Wolchok, J., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.04.008 · Cited by 650
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Ulrich, C. M., Bigler, J., & Potter, J. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1801 · Cited by 548
Next-generation biomarkers for detecting kidney toxicity
Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P., & Dieterle, F. (2010) · Nature Biotechnology · doi:10.1038/nbt0510-436 · Cited by 538
Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A., & Kalluri, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300012200 · Cited by 538
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Antiviral Drug-Induced Nephrotoxicity
Izzedine, H., Launay-Vacher, V., & Deray, G. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.02.010 · Cited by 423
Renal Vulnerability to Drug Toxicity
Perazella, M. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02050309 · Cited by 403
Self-citationToxic acute tubular necrosis following treatment with zoledronate (Zometa)
Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00071.x · Cited by 384
Drug-induced acute interstitial nephritis
Perazella, M. A., & Markowitz, G. S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.71 · Cited by 378
Self-citationPerazella, M. A., & Markowitz, G. S. (2008) · Kidney International · doi:10.1038/ki.2008.356 · Cited by 363
Self-citationKidney-on-a-Chip technology for drug-induced nephrotoxicity screening
Wilmer, M. J., Ng, C. P., Lanz, H. L., Vulto, P., Suter-Dick, L., & Masereeuw, R. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.11.001 · Cited by 354 · cited 3×
“These in vitro models, in particular the 3D models, are thought to more reliably replicate the in vivo environment and predict nephrotoxicity that occurs with certain drugs in the clinical setting (81).”
BackgroundOnco-Nephrology: Renal Toxicities of Chemotherapeutic Agents
Perazella, M. A. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02780312 · Cited by 350
Self-citationCrystal-induced acute renal failure
Perazella, M. A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00041-8 · Cited by 322
Self-citationDickenmann, M., Oettl, T., & Mihatsch, M. J. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.10.044 · Cited by 311
Nagai, J., & Takano, M. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.159 · Cited by 297
Perazella, M. A., & Moeckel, G. W. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.09.005 · Cited by 287
Self-citationShirali, A. C., Perazella, M. A., & Gettinger, S. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.02.057 · Cited by 284
Self-citationIsnard Bagnis, C., Deray, G., Baumelou, A., Le Quintrec, M., & Vanherweghem, J. L. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.009 · Cited by 244
Association between ABCC2 Gene Haplotypes and Tenofovir‐Induced Proximal Tubulopathy
Izzedine, H., Hulot, J., Villard, E., Goyenvalle, C., Dominguez, S., Ghosn, J., Valantin, M. A., Lechat, P., & Deray, A. G. (2006) · The Journal of Infectious Diseases · doi:10.1086/508546 · Cited by 243
Luther, M. K., Timbrook, T. T., Caffrey, A. R., Dosa, D., Lodise, T. P., & LaPlante, K. L. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002769 · Cited by 235
Drug-Induced Renal Failure: Update on New Medications and Unique Mechanisms of Nephrotoxicity
Perazella, M. A. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200306000-00006 · Cited by 225
Self-citationGambaro, G., & Perazella, M. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01146.x · Cited by 225
Self-citationAcute Kidney Injury and Increasing Nephrotoxic-Medication Exposure in Noncritically-Ill Children
Moffett, B. S., & Goldstein, S. L. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08110910 · Cited by 216
Izzedine, H., Escudier, B., Lhomme, C., Pautier, P., Rouvier, P., Gueutin, V., Baumelou, A., Derosa, L., Bahleda, R., Hollebecque, A., et al. (2014) · Medicine · doi:10.1097/md.0000000000000207 · Cited by 187
Drug-induced renal failure: a focus on tubulointerstitial disease
Markowitz, G. S., & Perazella, M. A. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.09.005 · Cited by 185
Self-citationWyatt, C. M., Arons, R. R., Klotman, P. E., & Klotman, M. E. (2006) · AIDS · doi:10.1097/01.aids.0000210610.52836.07 · Cited by 184
Enomoto, A., & Endou, H. (2005) · Clinical and Experimental Nephrology · doi:10.1007/s10157-005-0368-5 · Cited by 181
Renal Effects of Anti-angiogenesis Therapy: Update for the Internist
Gurevich, F., & Perazella, M. A. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.11.025 · Cited by 170
Self-citationVEGF regulates local inhibitory complement proteins in the eye and kidney
Keir, L. S., Firth, R., Aponik, L., Feitelberg, D., Sakimoto, S., Aguilar, E., Welsh, G. I., Richards, A., Usui, Y., Satchell, S. C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86418 · Cited by 154
The Urine Sediment as a Biomarker of Kidney Disease
Perazella, M. A. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.02.342 · Cited by 152
Self-citationVancomycin-Associated Cast Nephropathy
Luque, Y., Louis, K., Jouanneau, C., Placier, S., Estève, E., Bazin, D. C., Rondeau, É., Letavernier, E., Wolfromm, A., Gosset, C., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016080867 · Cited by 152
Involvement of Drug-Specific T Cells in Acute Drug-Induced Interstitial Nephritis
Spanou, Z., Keller, M., Britschgi, M., Yawalkar, N., Fehr, T., Neuweiler, J., Gugger, M., Mohaupt, M., & Pichler, W. J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050418 · Cited by 151
Markowitz, G. S., & Perazella, M. A. (2009) · Kidney International · doi:10.1038/ki.2009.308 · Cited by 145
Self-citationThe nephrotoxic effects of HAART
Izzedine, H., Harris, M., & Perazella, M. A. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.142 · Cited by 144
Self-citationUse of Transcriptomics in Understanding Mechanisms of Drug-Induced Toxicity
Cui, Y., & Paules, R. S. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.37 · Cited by 138
Intravenous immunoglobulin and the kidney—a two-edged sword
Orbach, H., Tishler, M., & Shoenfeld, Y. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2004.06.003 · Cited by 134
Drug-Induced Acute Interstitial Nephritis
Moledina, D. G., & Perazella, M. A. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07630717 · Cited by 133
Self-citationPolymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non–Small Cell Lung Cancer Patients
Suk, R. N., Gurubhagavatula, S., Park, S., Zhou, W., Li, S., Lynch, T. J., Wain, J. C., Neuberg, D. S., Liu, G., & Christiani, D. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1953 · Cited by 128
Drug use and nephrotoxicity in the intensive care unit
Perazella, M. A. (2010) · Kidney International · doi:10.1038/ki.2010.475 · Cited by 124
Self-citationHow to prevent, recognize, and treat drug-induced nephrotoxicity.
Guo, X., & Nzerue, C. M. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.4.289 · Cited by 117
Petros, W. P., Hopkins, P. J., Spruill, S. E., Broadwater, G., Vredenburgh, J. J., Colvin, O. M., Peters, W. P., Jones, R. B., Hall, J., & Marks, J. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.075 · Cited by 113
Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy
Perazella, M. A. (2010) · Kidney International · doi:10.1038/ki.2010.344 · Cited by 112
Self-citationRenal Transport of Antibiotics and Nephrotoxicity: a Review
Fanos, V., & Cataldi, L. (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.5.461 · Cited by 110
New drug toxicities in the onco-nephrology world
Perazella, M. A., & Izzedine, H. (2015) · Kidney International · doi:10.1038/ki.2015.30 · Cited by 86
Self-citationCisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53
Sprowl, J. A., Lancaster, C. S., Pabla, N., Hermann, E., Kosloske, A. M., Gibson, A. A., Li, L., Zeeh, D., Schlatter, E., Janke, L. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0319 · Cited by 83
Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity
Aleksa, K., Matsell, D. G., Krausz, K., Gelboin, H. V., Ito, S., & Koren, G. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1807-3 · Cited by 82
(2015) · Iranian Journal of Kidney Diseases · Cited by 82
Singh, N. P., Ganguli, A., & Prakash, A. (2003) · PubMed · Cited by 78
Nephrotoxic effects of designer drugs: synthetic is not better!
Luciano, R. L., & Perazella, M. A. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.44 · Cited by 74
Self-citationStudy of Renal Safety in Amphotericin B Lipid Complex–Treated Patients
Alexander, B. D., & Wingard, J. R. (2005) · Clinical Infectious Diseases · doi:10.1086/429335 · Cited by 73
Jerkić, M., Vojvodić, S., & López-Novoa, J. M. (2001) · International Urology and Nephrology · doi:10.1023/a:1014484101427 · Cited by 65
Increased propensity for calcium phosphate kidney stones with topiramate use
Vega, D., Maalouf, N. M., & Sakhaee, K. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.547 · Cited by 64
Evenepoel, P. (2004) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2003.09.007 · Cited by 62
Mimicking the Kidney: A Key Role in Organ-on-Chip Development
Paoli, R., & Samitier, J. (2016) · Micromachines · doi:10.3390/mi7070126 · Cited by 57
Ciprofloxacin Crystal Nephropathy
Stratta, P., Lazzarich, E., Canavese, C., Bozzola, C., & Monga, G. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.014 · Cited by 56
Aminoglycoside Dosages and Nephrotoxicity
Rougier, F., Ducher, M., Maurin, M., Corvaisier, S., Claude, D., Jelliffe, R. W., & Maire, P. H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00007 · Cited by 55
Zonisamide and renal calculi in patients with epilepsy: how big an issue?
Wroe, S. J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x210499 · Cited by 45
Proton Pump Inhibitors and CKD
Moledina, D. G., & Perazella, M. A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020192 · Cited by 44
Self-citationHucke, A., & Ciarimboli, G. (2016) · Journal of clinical pharmacology · doi:10.1002/jcph.706 · Cited by 36
Aminoglycoside-associated nephrotoxicity in extrahepatic obstructive jaundice
Lucena, M. I., Andrade, R. J., Cabello, M. R., Hidalgo, R., Correa, J. A. G., & de la Cuesta, F. S. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80428-5 · Cited by 35
Nephrotoxicity of over-the-counter analgesics, natural medicines, and illicit drugs
Blowey, D. L. (2005) · Adolescent Medicine Clinics · doi:10.1016/j.admecli.2004.10.001 · Cited by 33
Checkmate: kidney injury associated with targeted cancer immunotherapy
Perazella, M. A. (2016) · Kidney International · doi:10.1016/j.kint.2016.05.024 · Cited by 33
Self-citationRace and Ethnicity in the Era of Emerging Pharmacogenomics
Harty, L. C., Johnson, K. J., & Power, A. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005286028 · Cited by 27
Imaging Patients With Kidney Disease: How Do We Approach Contrast-Related Toxicity?
Perazella, M. A., & Reilly, R. F. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181f016e6 · Cited by 26
Self-citationRationale and Design of the Genetic Contribution to Drug Induced Renal Injury (DIRECT) Study
Awdishu, L., Nievergelt, C. M., Davenport, A., Murray, P. T., Macedo, E. M., Cerdá, J., Chakaravarthi, R., Rao, S. P. R., Holden, A. L., Goldstein, S. L., et al. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.08.010 · Cited by 11
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Drug-Induced Acute Kidney Injury
Perazella, M. A., & Rosner, M. H. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11290821 · Cited by 357
Self-citationWeng, Q., Sun, H., Fang, C., Xia, F., Liao, H., Lee, J., Wang, J., Xie, A., Ren, J., Guo, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21714-2 · Cited by 302
Tanase, D. M., Gosav, E. M., Radu, S., Costea, C. F., Ciocoiu, M., Carauleanu, A., Lacatusu, C. M., Maranduca, M. A., Floria, M., & Rezus, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205238 · Cited by 191
Metadata
- Authors
- Perazella, M. A.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2018-04-05
- Volume
- 13
- Issue
- 12
- Pages
- 1897-1908
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2795392618
- Cited by
- 270
- References
- 75
- FWCI
- 13.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.